SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is experiencing significant volatility and downward pressure as shareholders react to a large-scale debt exchange involving the conversion of convertible notes into equity. The community remains deeply divided, with some expressing frustration over share dilution and management's strategy, while others view the move as a long-term play to strengthen the balance sheet for future acquisitions.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as retail investors rally around a potential short squeeze, fueled by high short interest and anticipation surrounding the company's Q2 earnings and first-ever formal financial guidance. The community remains heavily focused on the company's shift toward AI infrastructure through the Northern Data acquisition and its strategic cloud partnerships, which bulls believe will fundamentally reprice the stock once institutional investors take note.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is seeing heavy community debate as investors reconcile a strong sales growth trajectory with recent earnings-related volatility and active short-selling pressure. Supporters remain focused on the long-term potential of its core franchise and pipeline, while actively discussing buyout rumors and the company's ability to maintain momentum against established pharmaceutical competitors.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is surging toward all-time highs as traders capitalize on a robust momentum rally, despite ongoing skepticism regarding potential peace talks with Iran and geopolitical tensions. Market participants are actively debating whether this rapid move is a sustainable bull trend or a classic short squeeze fueled by aggressive buying in mega-cap tech stocks.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is trending as investors debate whether the current price action is an attractive buying opportunity or a warning sign ahead of earnings. Community discussion is split between bullish sentiment over long-term growth and market share gains, and bearish concerns regarding high short interest, margin pressures, and intense competition in the energy drink sector.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors and the community closely track the timing of the anticipated IZAR-1 Phase 3 clinical data, with ongoing debates over potential trial outcomes and the company's valuation. Market participants are actively discussing the possibility of a near-term data releaseoften tied to the CEO's 'about a month' guidancewhile weighing the stock's recent performance against its high institutional ownership and the potential for a significant re-rating upon successful results.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending as investors weigh recent FAA certification progress and a robust Farnborough Airshow order book against concerns over near-term cash flow and defense-related cost overruns. While the community is actively debating the stock's potential for an earnings-driven breakout, sentiment remains divided between those viewing the current price as a long-term value opportunity and those frustrated by continued volatility and production hurdles.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is currently trending as investors brace for the upcoming earnings call, with community sentiment deeply polarized between frustration over stagnant share price performance and optimism surrounding the potential for proprietary Matrix-M licensing deals. The discussion is heavily focused on the company's strategic pivot toward a leaner licensing model, with many participants intensely scrutinizing management's communication and the long-term value of their combination vaccine pipeline.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending as the community debates its upcoming earnings report, with sentiment split between high expectations for revenue acceleration in commercial AI and concerns over its premium valuation. Traders are closely monitoring the massive implied volatility and options activity, while long-term investors highlight the company's expanding role in defense and data infrastructure as key catalysts for future growth.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is experiencing a sharp rebound as investors look past analyst price-target cuts to focus on the company's record revenue growth and membership expansion. The community remains deeply divided, with bulls pointing to the digital-first banking flywheel as a long-term play, while bears express skepticism about earnings quality and persistent short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$JCAP:  Jefferson Capital prices secondary offering of 10.0 mln shares of common stock at $20.50 per share

Robert Fitch

StockTwits Web

Jefferson Capital Inc.

:  Jefferson Capital prices secondary offering of 10.0 mln shares of common stock at $20.50 per share